Neuronetics, Inc. (FRA:NRC)

Market Cap	77.57M -70.0%
Revenue (ttm)	127.04M +99.2%
Net Income	-33.21M
EPS	-0.50
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	1.144
Previous Close	1.242
Day's Range	1.142 - 1.210
52-Week Range	1.016 - 4.010
Beta	n/a
RSI	49.62
Earnings Date	Mar 17, 2026

About Neuronetics

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 658
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NRC

Financial Performance

In 2025, Neuronetics's revenue was $149.16 million, an increase of 99.17% compared to the previous year's $74.89 million. Losses were -$39.00 million, -10.78% less than in 2024.

Financial numbers in USD